BLOOD TYPES AS TUMOR- ASSOCIATED CARBOHYDRATE ANTIGENS THAT DETERMINE THE EFFICACY OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN LUNG CANCER.

Children'S Hospital Corporation, The

Investigators